What is the recommended VTE prophylaxis for a 45-year-old pregnant female at 35 weeks gestational age, scheduled for a cesarean section, with a BMI of 31 and no history of DVT or coagulopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

VTE Prophylaxis for Cesarean Section in a 45-Year-Old Woman with Obesity

This patient requires both enoxaparin and sequential compression devices (Answer A). 1, 2

Risk Factor Assessment

This patient has two minor risk factors that together mandate pharmacologic prophylaxis:

  • Advanced maternal age (45 years) - classified as a minor risk factor for VTE 2
  • Obesity (BMI 31, Class I obesity) - represents a minor risk factor for VTE 1, 2
  • Cesarean delivery - inherently increases VTE risk compared to vaginal delivery 2

The American College of Chest Physicians establishes that at least two minor risk factors indicate a VTE risk above 3%, warranting pharmacologic thromboprophylaxis in addition to mechanical prophylaxis. 2

Recommended Prophylaxis Strategy

Mechanical Prophylaxis (Universal for All Cesarean Deliveries)

All women undergoing cesarean delivery must receive sequential compression devices starting before surgery and continuing until fully ambulatory (GRADE 1C). 3, 1, 2 This is non-negotiable regardless of other risk factors. 3

Pharmacologic Prophylaxis (Required for This Patient)

Enoxaparin 40 mg subcutaneously once daily is the preferred agent for pharmacologic prophylaxis (GRADE 1C). 1, 2 Low-molecular-weight heparin is specifically recommended as the preferred thromboprophylactic agent in pregnancy and the postpartum period. 3, 2

For this patient with Class I obesity (BMI 31), standard prophylactic dosing of enoxaparin 40 mg daily is appropriate. 2 Intermediate doses are only suggested for Class III obesity (BMI ≥40). 3, 2

Duration of Prophylaxis

  • Mechanical prophylaxis: Continue until the patient is fully ambulatory 1, 2
  • Pharmacologic prophylaxis: Initiate postoperatively and continue for at least 10 days, with consideration for extension to 6 weeks if additional risk factors persist 1, 2

Why Other Options Are Inadequate

Option B (vitamins only) is completely inappropriate - pregnancy vitamins provide no VTE prophylaxis, and this patient's risk profile mandates active intervention. 1, 2

Option C (early ambulation alone) is insufficient. While early ambulation is appropriate for vaginal delivery with obesity as the only risk factor, cesarean delivery combined with obesity and advanced age requires both mechanical and pharmacologic prophylaxis. 1

Option D (aspirin) has no role in VTE prophylaxis after cesarean delivery. Antiplatelet agents do not prevent venous thromboembolism. 3, 2

Clinical Implementation

Apply sequential compression devices preoperatively, initiate enoxaparin 40 mg subcutaneously once daily postoperatively (typically 6-12 hours after surgery if no bleeding concerns), and continue compression devices until fully ambulatory. 1, 2 Continue enoxaparin for at least 10 days, extending to 6 weeks given the persistent risk factors of age and obesity. 1, 2

Common Pitfalls to Avoid

Do not withhold pharmacologic prophylaxis based on obesity alone being considered "minor" - the combination of two or more minor risk factors (age 45 + obesity + cesarean delivery) elevates this patient to requiring full prophylaxis. 2 The Society for Maternal-Fetal Medicine recommends that each institution develop a standardized protocol for VTE prophylaxis to prevent such omissions. 3, 2

Do not delay enoxaparin initiation excessively - studies demonstrate safety of administration within 24 hours of cesarean section, even with epidural anesthesia, with no increased risk of spinal epidural hematoma. 4

budget:token_budget Tokens used this turn: 4426 Total tokens used in conversation: 4426 Remaining token budget: 195574

References

Guideline

DVT Prevention After Delivery in Overweight Pregnant Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

VTE Prophylaxis for Cesarean Section

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Enoxaparin administration within 24 hours of caesarean section: a 6-year single-centre experience and patient outcomes.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2019

Related Questions

What is the recommended Lovenox (enoxaparin) regimen for thromboprophylaxis in patients undergoing cesarean section?
What is the management for a post-cesarean section patient with a DVT?
What is the optimal timing for administering enoxaparin (Low Molecular Weight Heparin, Lovenox) after a cesarean section?
Is Lovenox (enoxaparin) routinely administered after a cesarean section (C-section)?
What is the recommended Venous Thromboembolism (VTE) prophylaxis for a 45-year-old pregnant woman at 35 weeks gestational age, with a Body Mass Index (BMI) of 31, scheduled for a Cesarean Section (C/S) and taking pregnancy vitamins?
What is the best advice for a 20-year married female patient with type 1 diabetes (T1D) for 20 years, hypertension treated with an angiotensin converting enzyme (ACE) inhibitor and a diuretic, and an HbA1c of 8.0%, who is planning to conceive?
What is the first line treatment for a patient presenting with scrotal cellulitis?
What is the recommended initial dose of push-dose Levophed (norepinephrine) for an adult patient with severe hypotension or shock?
What is the duration of action of immediate-release Dilaudid (hydromorphone)?
Do exogenous ketones have benefits for a generally healthy adult, particularly for weight loss or athletic performance, considering potential risks and interactions with medical conditions such as diabetes?
What is the recommended dosage and frequency of artificial tears, such as Systane Ultra (polyethylene glycol) or Refresh Optive (carboxymethylcellulose), for a patient with dry eye symptoms?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.